NASDAQ$LMAT

LeMaitre Vascular Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

LeMaitre Vascular's Q1 2024 financial performance demonstrated strong growth and improved profitability.

LeMaitre Vascular reported a strong Q1 2024 with a 14% increase in sales, driven by allografts, bovine patches, carotid shunts, and distributed porcine patches. The company's gross margin improved by 300 bps to 68.6%, and operating income increased by 51%.

  • Sales increased by 14% compared to Q1 2023, with organic growth of 11%.
  • Gross margin improved to 68.6%, a 300 bps increase from the previous year.
  • Operating income grew by 51% year-over-year, reaching $11.9 million.
  • Net income increased by 64% compared to Q1 2023.

Headline financials

Total Revenue

$53.5M

Previous: $47.1M+13.6%
EPS

$0.44

Previous: $0.27+63.0%
Gross Margin

68.6%

No prior period
Adjusted EBITDA

$14.2M

No prior period
Free Cash Flow

$9.89M

Previous: $6.04M+63.7%
Net Income

$9.89M

Previous: $6.04M+63.7%
Operating Income

$11.9M

Previous: $7.87M+50.8%
Gross Profit

$36.7M

Previous: $30.9M+18.7%
R&D Expense

$4.09M

No prior period
Stock-Based Comp

$1.61M

Previous: $1.29M+24.8%

Revenue & EPS history

LeMaitre Vascular · Revenue · Quarterly

$53.5M

Q1 2024+13.6%vs Q1 2023
Beat estimate in 8 of 15 quarters(53%)
ActualEstimate

Forward guidance

LeMaitre provided guidance for Q2 2024 and full year 2024, including sales, gross margin, operating income, and EPS.

Tailwinds

  • Q2 2024 Sales: $53.7mm - $56.1mm (Mid: $54.9mm, +10% organic)
  • Q2 2024 Gross Margin: 68.6%
  • Q2 2024 Operating Income: $12.0mm - $13.7mm (Mid: $12.9mm, +36%)
  • Q2 2024 EPS: $0.45 - $0.50 (Mid: $0.47, +31%)
  • Full Year 2024 Sales: $212.7mm - $217.3mm (Mid: $215.0mm, +11% organic)

Headwinds

  • Full Year 2024 Gross Margin: 68.6%
  • Full Year 2024 Operating Income: $46.7mm - $49.8mm (Mid $48.3mm, +31%)
  • Full Year 2024 Operating Margin (Mid): 22%
  • Full Year 2024 EPS: $1.73 - $1.84 (Mid: $1.79, +33%)
  • Special charges in 2023 were related to the St. Etienne factory closure.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+1.2%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+1.5%

Avg return

30 days after

52%

34 / 65 earnings

Positive

+24.3%

Q1 2017

Best reaction

-22.1%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.6%-9.3%-15.7%
Q4 2025+24.2%+18.0%+16.7%
Q3 2025+1.4%+5.1%-1.2%
Q1 2025-13.0%-9.6%-8.9%
Q4 2024-8.1%-12.9%-16.9%
Q3 2024+6.5%+10.8%+20.1%
Q2 2024-2.2%-5.8%+3.9%
Q1 2024+11.1%+13.7%+18.1%
Q4 2023+15.2%+9.5%+7.6%
Q3 2023-4.0%+1.3%+10.8%
Q2 2023+2.3%-10.1%-8.6%
Q1 2023+15.4%+23.6%+17.1%
Q4 2022+6.2%+3.7%+5.2%
Q3 2022-19.6%-17.4%-11.5%
Q2 2022+4.7%+7.1%+3.8%
Q1 2022-2.9%-0.2%+2.6%
Q4 2021+6.2%+9.1%+3.0%
Q3 2021-5.2%-3.9%-11.2%
Q2 2021-0.5%+2.3%+2.9%
Q1 2021-2.8%-4.9%-5.1%
Q4 2020+7.8%+7.8%-2.0%
Q3 2020-1.7%+5.6%+19.8%
Q2 2020+13.3%+4.4%+3.9%
Q1 2020-14.1%-14.9%-12.4%
Q4 2019-20.1%-20.0%-23.6%
Q3 2019-1.5%+0.8%+1.8%
Q2 2019+0.8%+1.0%-4.4%
Q1 2019-8.2%-4.1%-10.6%
Q4 2018+22.3%+18.0%+24.3%
Q3 2018-22.1%-27.3%-25.8%
Q2 2018-7.1%-3.6%-4.5%
Q1 2018-16.6%-18.9%-16.2%
Q4 2017+1.6%+0.4%+0.9%
Q3 2017-17.7%-15.7%-8.2%
Q2 2017+17.4%+19.2%+17.9%
Q1 2017+24.3%+18.5%+17.9%
Q4 2016-6.9%-6.8%+1.3%
Q3 2016+9.4%+8.6%+24.9%
Q2 2016+15.1%+24.1%+21.4%
Q1 2016-1.4%
Q4 2015+18.5%
Q3 2015+11.0%
Q2 2015+14.0%
Q1 2015+0.0%
Q4 2014+2.2%
Q3 2014+3.0%
Q2 2014+3.5%
Q1 2014+4.6%
Q4 2013-2.2%
Q3 2013-1.4%
Q2 2013+1.2%
Q1 2013+1.5%
Q4 2012+3.3%
Q3 2012-0.6%
Q2 2012+1.6%
Q1 2012+0.3%
Q4 2009-1.2%
Q4 2011-1.2%
Q3 2010-1.9%
Q3 2011-1.9%
Q4 2010+0.1%
Q2 2011+0.1%
Q2 2010+0.1%
Q1 2011-1.1%
Q1 2010-3.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro